MYC and lymphoma: Since we had observed potential differences in CHK2 levels in Eμ-Myc/cRel−/− lymphoma cells (Figure 3C), we investigated whether these CCT244747 resistant U2OS cells acquire sensitivity to CHK2 inhibition.